{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:08:44Z","timestamp":1790813324115,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The major program of Summit Project, Guangdong Province High-level Hospital Construction Project of Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences","award":["DFJH2020025"],"award-info":[{"award-number":["DFJH2020025"]}]},{"name":"The major program of Summit Project, Guangdong Province High-level Hospital Construction Project of Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences","award":["DFJH2020025"],"award-info":[{"award-number":["DFJH2020025"]}]},{"name":"The major program of Summit Project, Guangdong Province High-level Hospital Construction Project of Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences","award":["DFJH2020025"],"award-info":[{"award-number":["DFJH2020025"]}]},{"name":"The major program of Summit Project, Guangdong Province High-level Hospital Construction Project of Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences","award":["DFJH2020025"],"award-info":[{"award-number":["DFJH2020025"]}]},{"name":"The major program of Summit Project, Guangdong Province High-level Hospital Construction Project of Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences","award":["DFJH2020025"],"award-info":[{"award-number":["DFJH2020025"]}]},{"name":"Guangdong Provincial People\u2019s Hospital Supporting Fund for NSFC Program","award":["8190010469"],"award-info":[{"award-number":["8190010469"]}]},{"name":"Guangdong Provincial People\u2019s Hospital Supporting Fund for NSFC Program","award":["8190010469"],"award-info":[{"award-number":["8190010469"]}]},{"name":"Guangdong Provincial People\u2019s Hospital Supporting Fund for NSFC Program","award":["8190010469"],"award-info":[{"award-number":["8190010469"]}]},{"name":"Guangdong Provincial People\u2019s Hospital Supporting Fund for NSFC Program","award":["8190010469"],"award-info":[{"award-number":["8190010469"]}]},{"name":"Guangdong Provincial People\u2019s Hospital Supporting Fund for NSFC Program","award":["8190010469"],"award-info":[{"award-number":["8190010469"]}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["B2021030"],"award-info":[{"award-number":["B2021030"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["B2021030"],"award-info":[{"award-number":["B2021030"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["B2021030"],"award-info":[{"award-number":["B2021030"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["B2021030"],"award-info":[{"award-number":["B2021030"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["B2021030"],"award-info":[{"award-number":["B2021030"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02980-8","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:00:32Z","timestamp":1751464832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study"],"prefix":"10.1007","volume":"16","author":[{"given":"Ling","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChengPing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanguo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caidi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinggui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuiNian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-e","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"2980_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"2980_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13045-024-01560-7","volume":"17","author":"EWY Chang","year":"2024","unstructured":"Chang EWY, Tan YH, Chan JY. Novel clinical risk stratification and treatment strategies in relapsed\/refractory peripheral T-cell lymphoma. J Hematol Oncol. 2024;17:38.","journal-title":"J Hematol Oncol"},{"key":"2980_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","volume":"138","author":"J Sun","year":"2012","unstructured":"Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M, et al. Distribution of lymphoid neoplasms in china: analysis of 4,638 cases according to the world health organization classification. Am J Clin Pathol. 2012;138:429\u201334.","journal-title":"Am J Clin Pathol"},{"key":"2980_CR4","first-page":"100126","volume":"10","author":"SE Yoon","year":"2021","unstructured":"Yoon SE, Song Y, Kim SJ, Yoon DH, Chen TY, Koh Y, et al. Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia. Lancet Reg Health West Pac. 2021;10:100126.","journal-title":"Lancet Reg Health West Pac"},{"key":"2980_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12943-023-01904-w","volume":"23","author":"Y Luan","year":"2024","unstructured":"Luan Y, Li X, Luan Y, Luo J, Dong Q, Ye S, et al. Therapeutic challenges in peripheral T-cell lymphoma. Mol Cancer. 2024;23:2.","journal-title":"Mol Cancer"},{"key":"2980_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-016-0267-0","volume":"9","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Xu W, Liu H, Li J. Therapeutic options in peripheral T cell lymphoma. J Hematol Oncol. 2016;9:37.","journal-title":"J Hematol Oncol"},{"key":"2980_CR7","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/S2352-3026(20)30207-6","volume":"7","author":"H Ma","year":"2020","unstructured":"Ma H, Marchi E, O\u2019Connor OA. The peripheral T-cell lymphomas: an unusual path to cure. Lancet Haematol. 2020;7:e765\u201371.","journal-title":"Lancet Haematol"},{"key":"2980_CR8","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1182\/blood.2023021789","volume":"144","author":"AJ Moskowitz","year":"2024","unstructured":"Moskowitz AJ, Stuver RN, Horwitz SM. Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs). Blood. 2024;144:1887\u201397.","journal-title":"Blood"},{"key":"2980_CR9","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology: T-cell lymphomas [version 1.2025]. 2024"},{"key":"2980_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","volume":"393","author":"S Horwitz","year":"2019","unstructured":"Horwitz S, O\u2019Connor OA, Pro B, Illidge T, Fanale M, Advani R, et al. Brentuximab Vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019;393:229\u201340.","journal-title":"Lancet"},{"key":"2980_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bjh.14477","volume":"176","author":"D Chihara","year":"2017","unstructured":"Chihara D, Fanale MA, Miranda RN, Noorani M, Westin JR, Nastoupil LJ, et al. The survival outcome of patients with relapsed\/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol. 2017;176:750\u20138.","journal-title":"Br J Haematol"},{"key":"2980_CR12","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","volume":"26","author":"Y Shi","year":"2015","unstructured":"Shi Y, Dong M, Hong X, Zhang W, Feng J, Zhu J, et al. Results from a multicenter, open-label, pivotal phase II study of Chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol. 2015;26:1766\u201371.","journal-title":"Ann Oncol"},{"key":"2980_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12185-018-2404-8","volume":"107","author":"Y Shi","year":"2018","unstructured":"Shi Y. Current status and progress of lymphoma management in China. Int J Hematol. 2018;107:405\u201312.","journal-title":"Int J Hematol"},{"key":"2980_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00277-008-0469-9","volume":"87","author":"MH Chen","year":"2008","unstructured":"Chen MH, Hsiao LT, Chiou TJ, Liu JH, Gau JP, Teng HW, et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin\u2019s lymphoma. Ann Hematol. 2008;87:475\u201380.","journal-title":"Ann Hematol"},{"key":"2980_CR15","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","volume":"124","author":"F Ellin","year":"2014","unstructured":"Ellin F, Landstr\u00f6m J, Jerkeman M, Relander T. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish lymphoma registry. Blood. 2014;124:1570\u20137.","journal-title":"Blood"},{"key":"2980_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/bjh.16741","volume":"192","author":"SM Rodriguez-Pinilla","year":"2021","unstructured":"Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Perez Seoane C, Lopez Jimenez J, et al. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. Br J Haematol. 2021;192:82\u201399.","journal-title":"Br J Haematol"},{"key":"2980_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1309\/AJCPWKJ3GPFRT7GA","volume":"138","author":"YL Ren","year":"2012","unstructured":"Ren YL, Nong L, Zhang S, Zhao J, Zhang XM, Li T. Analysis of 142 Northern Chinese patients with peripheral T\/NK-Cell lymphomas: subtype distribution, clinicopathologic features, and prognosis. Am J Clin Pathol. 2012;138:435\u201347.","journal-title":"Am J Clin Pathol"},{"key":"2980_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin. 2005;55:368\u201376.","journal-title":"CA Cancer J Clin"},{"key":"2980_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579\u201386.","journal-title":"J Clin Oncol"},{"key":"2980_CR20","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"2980_CR21","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK\u2009+\u2009ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the international peripheral T-Cell lymphoma project. Blood. 2008;111:5496\u2013504.","journal-title":"Blood"},{"key":"2980_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5581\/1516-8484.20120013","volume":"34","author":"M Bellei","year":"2012","unstructured":"Bellei M, Chiattone CS, Luminari S, Pesce EA, Cabrera ME, de Souza CA, et al. T-cell lymphomas in South America and Europe. Rev Bras Hematol Hemoter. 2012;34:42\u20137.","journal-title":"Rev Bras Hematol Hemoter"},{"key":"2980_CR23","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00277-019-03694-y","volume":"98","author":"A Janikova","year":"2019","unstructured":"Janikova A, Chloupkova R, Campr V, Klener P, Hamouzova J, Belada D, et al. First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients. Ann Hematol. 2019;98:1961\u201372.","journal-title":"Ann Hematol"},{"key":"2980_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jcv.2014.07.005","volume":"61","author":"W Li","year":"2014","unstructured":"Li W, Huang L, Guo H, Wei X, Liang Z. Antiviral efficacy analysis of Telbivudine concurrent with the first cycle of chemotherapy in HBsAg-positive lymphoma patients. J Clin Virol. 2014;61:199\u2013203.","journal-title":"J Clin Virol"},{"key":"2980_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/10428194.2021.1971220","volume":"63","author":"HD Kim","year":"2022","unstructured":"Kim HD, Cho H, Sohn BS, Park CS, Huh J, Ryu JS, et al. Prognostic significance of serum \u03b22-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified. Leuk Lymphoma. 2022;63:124\u201330.","journal-title":"Leuk Lymphoma"},{"key":"2980_CR26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1182\/blood.2021015114","volume":"140","author":"M Brink","year":"2022","unstructured":"Brink M, Meeuwes FO, van der Poel MWM, Kersten MJ, Wondergem M, Mutsaers P, et al. Impact of Etoposide and ASCT on survival among patients aged\u2009<\u200965 years with stage II to IV PTCL: a population-based cohort study. Blood. 2022;140:1009\u201319.","journal-title":"Blood"},{"key":"2980_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41408-023-00868-w","volume":"13","author":"DW Baek","year":"2023","unstructured":"Baek DW, Moon JH, Lee JH, Kang KW, Lee HS, Eom HS, et al. Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation. Blood Cancer J. 2023;13:95.","journal-title":"Blood Cancer J"},{"key":"2980_CR28","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","volume":"98","author":"B Bisig","year":"2013","unstructured":"Bisig B, de Reyni\u00e8s A, Bonnet C, Sujobert P, Rickman DS, Marafioti T, et al. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica. 2013;98:1250\u20138.","journal-title":"Haematologica"},{"key":"2980_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00277-022-04759-1","volume":"101","author":"A Janikova","year":"2022","unstructured":"Janikova A, Michalka J, Chloupkova R, Kopalova N, Campr V, Kamaradova K, et al. Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech lymphoma study group database (NIHIL). Ann Hematol. 2022;101:789\u201398.","journal-title":"Ann Hematol"},{"key":"2980_CR30","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1182\/blood-2013-12-542142","volume":"123","author":"SM Horwitz","year":"2014","unstructured":"Horwitz SM, Advani RH, Bartlett NL, Jacobsen ED, Sharman JP, O\u2019Connor OA, et al. Objective responses in relapsed T-cell lymphomas with single-agent Brentuximab Vedotin. Blood. 2014;123:3095\u2013100.","journal-title":"Blood"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02980-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:00:34Z","timestamp":1751464834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02980-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2980"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02980-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to the Declaration of Helsinki principles and approved by the Institutional Review Board of Guangdong Provincial People\u2019s Hospital (KY-Q-2021-225-02) and each participating center, waiving the requirement for patient consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1252"}}